Antiangiogenic effects and transcriptional regulation of pigment epithelium-derived factor in diabetic retinopathy

Microvascular Research

Volumn 80, Issue 1, 2010, Pages 31-36

  Wang, Binhui ^a   Atherton, Philip ^a   Patel, Rekha ^a   Manning, Gillian ^a   Donnelly, R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Angiogenesis; Diabetes; Pigment epithelium derived factor (PEDF); Retinopathy; Transcription; Vascular tubule formation; VEGF

Indexed keywords

GLUCOSE; INSULIN; PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CAPILLARY ENDOTHELIUM; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA BLOOD VESSEL; RETINA CAPILLARY; TRANSCRIPTION REGULATION; VASCULAR ENDOTHELIUM;

ANDROSTADIENES; ANGIOSTATIC PROTEINS; ANIMALS; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; ENZYME INHIBITORS; EYE PROTEINS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; INSULIN; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE GROWTH FACTORS; RETINAL VESSELS; SERPINS; SIROLIMUS; UMBILICAL CORD; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

BOVINAE;

EID: 77953545224     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.02.012     Document Type: Article

References (37)

1. Abaci A., Oguzhan A., Kahraman S., Eryol N.K., Unal S., Arinc H., Ergin A. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999, 99:2239-2242.
2. Arun C.S., Pandit R., Taylor R. Long-term progression of retinopathy after initiation of insulin therapy in type 2 diabetes: an observational study. Diabetologia 2004, 47:1380-1384.
3. Barnstable C.J., Tombran-Tink J. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential. Prog. Retin. Eye Res. 2004, 23:561-577.
4. Ben-Mahmud B.M., Mann G.E., et al. Tumor Necrosis Factor-alpha in diabetic plasma increases the activity of core-2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: significance of Core 2 GlcNAc-T in diabetic retinopathy. Diabetes 2004, 53:2968-2976.
5. Bishop E.T., Bell G.T., Bloor S., Broom I.J., Hendry N.F., Wheatley D.N. An in vitro model of angiogenesis: basic features. Angiogenesis 1999, 3:335-344.
6. Boehm B.O., Lang G., Volpert O., Jehle P.M., Kurkhaus A., Rosinger S., Lang G.K., Bouck N. Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humour predicts progression of diabetic retinopathy. Diabetologia 2003, 46:394-400.
7. Bussolati B., Dunk C., Grohman M., Kontos C.D., Mason J., Ahmed A. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am. J. Pathol. 2001, 159:993-1008.
8. Cao W., Tombran-Tink J., Elias R., Sezate S., Mrazek D., McGinns J.F. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest. Ophthalmol. Vis. Sci. 2001, 42:1646-1652.
9. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 2000, 6:389-395.
10. Chiarelli F., Spagnoli A., Basciani F., Tumini S., Mezzetti A., Cipollone F., Cuccurullo F., Morgese G., Verrotti A. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: relation to glycaemic control and microvascular complications. Diabet. Med. 2000, 17:650-656.
11. Chibber R., Molinatti P.A., Kohner E.M. Intracellular protein glycation in cultured retinal capillary pericytes and endothelial cells exposed to high-glucose concentration. Cell. Mol. Biol. 1999, 45:47-57.
12. Dawson D.W., Volpert O.V., Gillis P., Crawford S.E., Xu H., Benedict W., Bouck N.P. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999, 285:245-248.
13. Donovan D., Brown N.J., Bishop E.T., Lewis C.E. Comparison of three in vitro human angiogenesis assays with capillaries formed in vivo. Angiogenesis 2001, 4:113.
14. Duh E.J., Yang H.S., Suzuma I., Miyagi M., Youngman E., Mori K., Katai M., Yan L., Suzuma K., West K., Davarya S., Tong P., Gehlbach P., Pearlman J., Crabb J.W., Aiello L.P., Campochiaro P.A., Zack D.J. Pigment epithelium-derived factor suppresses ischaemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest. Ophthalmol. Vis. Sci. 2002, 43:821-829.
15. Gao G., Li Y., Zhang D., Gee S., Crosson C., Ma J. Unbalanced expression of VEGF and PEDF in ischaemia-induced retinal neovascularisation. FEBS Lett. 2001, 489:270-276.
16. Gao G., Li Y., Fant J., Crosson C.E., Becerra S.P., Ma J.-X. Difference in ischaemic regulation of vascular endothelial growth factor and pigment epithelium-derived factor in brown Norway and Sprague Dawley rats contributing to different susceptibilities to retinal neovascularisation. Diabetes 2002, 51:1218-1225.
17. Iizuka H., Awata T., Osaki M., Neda T., Kurihara S., Inoue K., et al. Promotor polymorphisms of the pigment epithelium-derived factor gene are associated with diabetic retinopathy. Biochem. Biophys. Res. Commun. 2007, 361:421-426.
18. Jenkins A.J., Zhang S.X., Rowley K.G., Karschimkus C.S., Nelson C.L., Chung J.S., et al. Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in type 1 diabetes. Diabet. Med. 2007, 24:1345-1351.
19. King G.L., Suzuma K. Pigment epithelium-derived factor - a key coordinator of retinal neuronal and vascular functions. N. Engl. J. Med. 2000, 342:349-351.
20. Larger E., Marre M., Corvol P., Gasc J.-M. Hyperglycaemia-induced defects in angiogenesis in the chicken chorioallantoic membrane model. Diabetes 2004, 53:752-761.
21. Matsuyama K., Ogata N., Matsuoka M., Shima C., Wada M., Jo N., Matsumura M. Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy. Mol. Vis. 2008, 14:992-996.
22. Mori K., Duh E., Gehlbach P., Ando A., Takahashi K., Pearlman J., Yang H.S., Zack D.J., Ettyreddy D., Brough D.E., Wei L.L., Campochiaro P.A. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularisation. J. Cell. Physiol. 2001, 188:253-263.
23. Ogata N., Tombran-Tink J., Nishikawa M., Nishimura T., Mitsuma Y., Sakamoto T., Matsumura M. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment. Am. J. Ophthalmol. 2001, 132:378-382.
24. Ogata N., Nishikawa M., Nishimura T., Mitsuma Y., Matsumura M. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am. J. Ophthalmol. 2002, 134:348-353.
25. Pfaffl M. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
26. Simcock D.E., Kanabar V., Clarke G.W., Mahn K., Karner C., O'Connor B.J., Lee T.H., Hirst S.J. Induction of angiogenesis by airway smooth muscle from patients with asthma. Am. J. Respir. Crit. Care Med. 2008, 178:460-468.
27. Simo R., Carrasco E., Garcia-Ramirez M., Hernandez C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr. Diabetes Rev. 2006, 2:71-98.
28. Spranger J., Osterhoff M., Reimann M., Mohlig M., Ristow M., Francis M.K., et al. Loss of antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye diseases. Diabetes 2001, 50:2641-2645.
29. Stellmach V., Crawford S.E., Zhou W., Bouck N. Prevention of ischaemia-induced retinopathy by the natural ocular anti-angiogenic agent pigment epithelium-derived factor. Proc. Natl Acad. Sci. U. S. A. 2001, 98:2593-2597.
30. Tombran-Tink J., Barnstable C.J. PEDF: a multifaceted neurotrophic factor. Nat. Rev. Neurosci. 2003, 4:628-636.
31. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc. Res. 2001, 49:554-560.
32. Wang J.J., Zhang S.X., Lu K., Chen Y., Mott R., Sato S., et al. Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy. Diabetes 2005, 54:243-250.
33. Wang J.J., Zhang S.X., Mott R., Knapp R.R., Cao W., Lau K., et al. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for anti-fibrogenic activities. Diabetes 2006, 55:1678-1685.
34. Wouters B.G., Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat. Rev. Cancer 2008, 8:851-864.
35. Yamagishi S., Adachi H., Abe A., Yashiro T., Enomoto M., Furuki K., et al. Elevated serum levels of pigment epithelium-derived factor (PEDF) in the metabolic syndrome. J. Clin. Endocrinol. Metab. 2006, 91:2447-2450.
36. Yoshida Y., Yamagishi S., Matsui T., Nakamura K., Imaizumi T., Yoshimura K., Yamakawa R. Positive correlation of pigment epithelium-derived factor and total antioxidant capacity in aqueous humour of patients with uveitis and proliferative diabetic retinopathy. Br. J. Ophthalmol. 2007, 91:1133-1134.
37. Zhang S.X., Wang J.J., Gao G., Shao C., Mott R., Ma J.-X. Pigment epithelium-derived factor (PEDF) is an endogenous anti-inflammatory factor. FASEB J. 2006, 20:323-325.